Compare Tyche Industries with Similar Stocks
Dashboard
Poor long term growth as Net Sales has grown by an annual rate of -8.35% and Operating profit at -49.08% over the last 5 years
With a fall in PBT of -24.42%, the company declared Very Negative results in Dec 25
With ROE of 4.8, it has a Expensive valuation with a 0.9 Price to Book Value
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
INR 124 Cr (Micro Cap)
20.00
39
2.48%
-0.19
4.77%
0.88
Total Returns (Price + Dividend) 
Latest dividend: 3 per share ex-dividend date: Sep-19-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Tyche Industries Ltd Valuation Shifts Signal Heightened Price Risk Amid Sector Challenges
Tyche Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift markedly, moving from an expensive to a very expensive rating. Despite a recent downgrade to a Strong Sell rating by MarketsMOJO, the stock’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios reveal a complex picture of price attractiveness relative to peers and historical benchmarks.
Read full news article
Tyche Industries Ltd Valuation Shift Signals Price Attractiveness Change
Tyche Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating. This change reflects evolving market perceptions and impacts the stock's price attractiveness relative to its historical averages and peer group, amid a challenging industry backdrop and mixed financial performance.
Read full news article
Tyche Industries Ltd is Rated Strong Sell
Tyche Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Feb 2026, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 06 April 2026, providing investors with the latest insights into its performance and outlook.
Read full news article Announcements 
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
09-Apr-2026 | Source : BSECompliance Certificate under Regulation 74(5) of SEBI(D&P)Regulations2018 for the Quarter ended March 31 2026
Closure of Trading Window
25-Mar-2026 | Source : BSEThe Trading window of the Company shall remain closed w.e.f April 1 2026 till the expiry of 48 hours after the declaration of the Audited Financial Results of the Company for the quarter and Year ended March 31 2026.
Intimation Regarding Receipt Of ANVISA Brazil GMP Certificate For The Companys Manufacturing Facility Located At Kakinada Andhra Pradesh.
24-Mar-2026 | Source : BSEPlease find attached the intimation regarding receipt of ANVISA Brazil GMP certificate for the Companys Manufacturing facility located at Kakinada Andhra Pradesh.
Corporate Actions 
No Upcoming Board Meetings
Tyche Industries Ltd has declared 30% dividend, ex-date: 19 Sep 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Silver Oak Technologies Private Limited (19.31%)
Plutus Techlabs Private Limited (6.4%)
26.51%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -25.28% vs 11.50% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 19.74% vs -37.45% in Sep 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -25.51% vs 8.98% in Sep 2024
Growth in half year ended Sep 2025 is -41.22% vs 14.87% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -30.42% vs -2.71% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -49.65% vs 13.02% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -5.81% vs -7.80% in Mar 2024
YoY Growth in year ended Mar 2025 is 1.39% vs -13.62% in Mar 2024






